[Summary IgA nephropathy, or Berger's disease].

Authors

Claire Bellanger, Khalil El Karoui

Published in

La Revue du praticien. Volume 76. Issue 7. Pages 772-776.

Abstract

IgA nephropathy (IgAN), or Berger's disease, is a common primary glomerulonephritis that presents a variety of clinical manifestations. The most typical presentation consists of episodes of gross hematuria in young adults, often occurring concurrently with upper respiratory tract infections. However, it may also present microscopic hematuria, varying degrees of proteinuria, renal insufficiency, or hypertension of varying severity. The diagnosis is based on kidney biopsy, which reveals IgA mesangial deposits. This condition may be associated with other systemic diseases that should be investigated. The course is heterogeneous, ranging from spontaneous remission to rapidly progressive forms. Prognostic factors - both clinical and biological (hypertension, proteinuria, renal function) and histopathological (Oxford classification criteria) - help guide therapeutic management. The cornerstone of treatment remains nephroprotection. The indication for immunomodulatory therapies should be assessed on a case-by-case basis. Numerous studies are currently underway to evaluate the effectiveness of promising new treatments targeting the production of pathogenic IgA or their inflammatory consequences within the glomeruli.

PMID:
42808624
Bibliographic data and abstract were imported from PubMed on 29 Sep 2026.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.